Carl J. Pepine, MD, is a doctor in the Division of Cardiovascular Medicine at the University of Florida College of Medicine. He graduated from the University of Pittsburgh in 1962 with his bachelor鈥檚 degree.
As he started medical school at Rutgers in New Jersey with his MD in 1966, Pepine stayed in the northeast for his internship at Allegheny General Hospital, a University of Pittsburgh affiliate. His two residencies were at Jefferson Medical College Hospital and Regional Naval Medical Center. He completed both fellowships in 1971 and became board certified in Internal Medicine and the subspeciality of Cardiovascular Disease.
He is currently a principal investigator of many NIH, DoD, and industry-funded research projects on cardiovascular disease in women, IHD, hypertension, heart failure, and cell-based therapy, with continuous peer-reviewed federal research funding (DoD, NIH, VA Merit) for over 40 years.
Pepine served as Chief of the UF Division of Cardiovascular Medicine from 1998鈥�2008 and Chief of Cardiology, Malcom Randall VA Medical Center, from 1978鈥�1994. He has published more than 1,200 scientific articles, edited 6 textbooks, and has been on the editorial boards of all major cardiovascular journals. He is the founding editor of Cardiology Today and Editor-in-Chief for American Heart Journal Plus: Cardiology Research and Practice. Pepine is currently on the Steering Committee of UF-CTSI.
The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-central nervous system (CNS) systemic embolism.
The primary objective of this study is to evaluate the effectiveness of early treatment with evolocumab plus routine lipid management vs routine lipid management alone when administered in the acute setting to reduce myocardial infarction, ischemic鈥�
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.
See all insurancesAugust 2, 2022
The University of Florida Center for Regenerative Medicine today announced the launch of a clinical trial to test safe dosages of umbilical cord-derived stem鈥�
Division of Rheumatology and Clinical Immunology, +4 more
June 22, 2022
When diagnostic tests for the heart were first created, scientists at the time did not fully consider that no two bodies are the same, especially between the鈥�
College of Nursing, +2 more
